Response Biomedical Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 10,853 11,801 9,304 7,158
Cost of Revenue 6,200 7,536 6,844 7,143
Gross Profit 4,652 4,264 2,460 16
Operating Expenses
Research and Development 2,261 2,966 2,801 4,133
Sales, General and Admin. 5,407 5,520 4,459 5,143
Non-Recurring Items - - - -
Other - - - -
Operating Income (3,016) (4,221) (4,799) (9,260)
Income From Continuing Operations
Add'l Income/Expense Items (1,936) (346) 375 (76)
Earnings Before Interest and Tax (4,952) (4,567) (4,426) (9,335)
Interest Expense 655 737 849 811
Earnings Before Tax (5,607) (5,304) (5,275) (10,146)
Income Tax 39 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,645) (5,304) (5,275) (10,146)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,645) (5,304) (5,275) (10,146)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,645) (5,304) (5,275) (10,146)